Is Apimeds Pharmaceuticals US a good buy right now?
USNYSE American: APUSNYSE Americanlast $0.6887 · 24 Jul 2026
Not yet — wait
Signal paused. APUS's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 28 Nov 2025 at $26 and closed on 1 Dec 2025 (−17.3%).
As of 30 Sep 2026 · Firefly Breakout Weekly
What happened after the last 7 buy signals on APUS
Oct 2024 – 30 Sep 20261 of 7 closed above the entry price, with an average outcome of −4.0% per signal before costs; a signal typically stayed open about 1 d. 2 trades touching a jump in the price data were left out.
| Buy signal | Price then | Closed | Held | Outcome |
|---|---|---|---|---|
| 28 Nov 2025 | $26 | 1 Dec 2025 | 3 d | -17.3% |
| 20 Nov 2025 | $27.2 | 21 Nov 2025 | 1 d | -16.2% |
| 19 Nov 2025 | $30.5 | 20 Nov 2025 | 1 d | -11.8% |
| 6 Nov 2025 | $25.5 | 17 Nov 2025 | 11 d | +56.9% |
| 5 Nov 2025 | $26.8 | 6 Nov 2025 | 1 d | -13.1% |
| 4 Nov 2025 | $27.3 | 4 Nov 2025 | 1 d | -11.4% |
| 3 Nov 2025 | $25.8 | 3 Nov 2025 | 1 d | -15.5% |
Outcomes are simulated by applying Firefly's rules to historical prices, before costs and slippage. Sell triggers are not counted: Firefly reads them as “don't enter”, not as short trades. Past behaviour of a rule is not a prediction of future prices.
The strategy behind this page
one rule set per market · beta| Strategy | Horizon | Signal | Since | Buy signals closed higher |
|---|---|---|---|---|
| Firefly Breakout Weekly | Medium term | No signal | — | 14% |
This beta publishes one rule set per market — Firefly Breakout Weekly — chosen in the October 2026 review. What the beta shows and how the data was cleaned →
Same theme beyond US
same theme, other marketsIndian peers are listed on the NSE and priced in rupees. Crypto gains are taxed at 30% in India with 1% TDS. Shown for context — not a recommendation to switch markets.
More questions about APUS
APUS share price today — buy or sell?
As of 30 Sep 2026, Firefly Breakout Weekly says wait on Apimeds Pharmaceuticals US. Signal paused. APUS's price history has a jump — most likely a split or bonus issue that was not adjusted — and 2 trades touching it were left out until the data is checked. The last Buy signal came on 28 Nov 2025 at $26 and closed on 1 Dec 2025 (−17.3%). The last price on record was $0.6887 on 24 Jul 2026.
How has Firefly's strategy done on Apimeds Pharmaceuticals US?
From October 2024 to 30 Sep 2026 Firefly's rules gave 7 buy signals on Apimeds Pharmaceuticals US; 1 closed above the entry price and the average outcome was −4.0% per signal, simulated on historical prices before costs. A handful of signals is a pattern, not a statistic.
What is the Apimeds Pharmaceuticals US price target?
We don't publish price targets — no rule-based system can forecast a price. Firefly Breakout Weekly closes each signal by its own rules; every closed signal on Apimeds Pharmaceuticals US and how it turned out is listed on this page.
Should I sell Apimeds Pharmaceuticals US?
No sell trigger is active on Apimeds Pharmaceuticals US as of 30 Sep 2026. This describes a rule, not advice on your position.
Why does this page show a single strategy?
This is the Signals beta. Each market publishes one rule set — here Firefly Breakout Weekly — instead of a vote across Firefly's whole library, and the verdict is its signal as of 30 Sep 2026. Sell triggers count as “don't enter”; only buy triggers are scored.
Fintrens shows how one of Firefly's rule-based strategies reads this stock. It is educational information, not investment advice and not a recommendation to buy or sell. We do not publish price targets. Indian residents buy US stocks under the RBI's Liberalised Remittance Scheme; tax is collected at source above the annual threshold. Read how Firefly's strategies work →